Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation
Cerebrovascular Diseases · 2025
DOI: 10.1159/000548288 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Xiaolei Lin und 14 weiteren Autor:innen. Beteiligte Einrichtung: Data Science, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Antihypertensive Agents, Hypertension, Blood Pressure. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Introduction: Elevated blood pressure (BP) is a key modifiable risk factor for cardiovascular (CV) complications in patients with atrial fibrillation (AF). While current guidelines recommend modest BP targets, the optimal target in AF patients remains uncertain. The Cardiovascular Risk Reduction in Atrial Fibrillation Trial (CRAFT) is a multicenter, prospective, randomized, open-label, blinded endpoint trial that evaluates whether intensive home systolic BP control (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Data Science, Fudan University, Shanghai, China.
- Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
- Heart Health Research Center, Beijing, China.
- Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
- The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Zitieren
APA
Lin, X., Jiang, C., Wang, Z., Arima, H., Wang, X., Billot, L., Neal, B., Rodgers, A., Hillis, G. S., Patel, A., Li, Q., Dong, J., Du, X., Anderson, C. S., & Ma, C. (2025). Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation. Cerebrovascular Diseases. https://doi.org/10.1159/000548288
Vancouver
Lin X, Jiang C, Wang Z, Arima H, Wang X, Billot L, et al. Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation. Cerebrovascular Diseases. 2025. doi:10.1159/000548288
BibTeX
@article{Lin2025,
author = {Lin, Xiaolei and Jiang, Chao and Wang, Zhiyan and Arima, Hisatomi and Wang, Xia and Billot, Laurent and Neal, Bruce and Rodgers, Anthony and Hillis, Graham S and Patel, Anushka and Li, Qiang and Dong, Jianzeng and Du, Xin and Anderson, Craig S and Ma, Changsheng},
title = {Statistical Analysis Plan for a Randomized Controlled Trial of Intensive Blood Pressure Control on Cardiovascular Risk Reduction in Patients with Atrial Fibrillation},
journal = {Cerebrovascular Diseases},
year = {2025},
doi = {10.1159/000548288}
}
EUVIMED